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Background: Depressive disorders are highly prevalent in the working population and are associated with
excessive costs for both society and companies. Effective treatment for employees with depressive symptoms in
occupational health care is limited. The purpose of this study is to investigate the effectiveness and cost-
effectiveness of an indicated preventive web-based guided self-help course for employees with depressive
symptoms.
Methods: The study is a two-arm randomized controlled trial comparing a web-based guided self-help course with
care-as-usual. The self-help course consists of 6 weekly lessons. Weekly support will be provided by a coach via the
website. Subjects in the care-as-usual group do not receive any treatment in addition to regular care. 200 white
collar workers from several national and international companies in the Netherlands will be recruited via different
methods such as banners on the company’s intranet, pamphlets and posters. Subjects will be included when they:
have elevated depressive symptoms (score ≥16 on the Center for Epidemiologic Studies Depression scale), are 18
years of age or older, have access to the Internet and can be contacted via e-mail. Exclusion criteria are: partial or
full work absenteeism, a legal labor dispute with the employer and receiving treatment from the company’s
occupational health care at study entrance.
The primary outcome is depressive symptoms. Secondary outcomes include work absenteeism, work performance,
burnout, anxiety, quality of life, health care use and production losses. Outcome data will be collected at 8 weeks, 6
months, and 12 months after baseline. Analyses will be based on the intention-to-treat principle. The cost-
effectiveness analyses will be performed from a societal and a company’s perspective. A process evaluation will be
conducted alongside the study.
Discussion: This study evaluates the effectiveness and cost-effectiveness of a web-based guided self-help course
for employees with depressive symptoms. This study could stimulate the use of e-mental health interventions in
the worksite setting.
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Depressive disorders and costs
Depressive disorders are highly prevalent in the general
[1-3] and working [4,5] population and lead to excessive
costs [6,7]. In the Netherlands, the lifetime prevalence of
major depressive disorder is 15.4% [8,9] and high costs
have been reported [10-14]. Smit et al. [11] calculated
and compared the total costs of common mental
disorders, such as mood disorders, anxiety disorders and
alcohol disorders in a Dutch population-based cohort
study. Mood disorders showed the highest total costs of
all common mental disorders. The per capita annual ex-
cess costs for a mood disorder were €5009, which equals
costs of €311 million per one million persons aged 18–
65 years. A substantial part of the total costs of depres-
sive disorders are due to work absenteeism, work im-
pairment, and loss of work productivity [11,15-21] with
estimates ranging between 70-85% [11,12,15]. In a recent
Dutch cohort study [10], the annual total costs for work
absenteeism due to depressive disorders were calculated
and estimated at €242 million per 1 million workers,
which equals €1.8 billion for the entire Dutch working
population. These costs are directly paid for by
companies.
Treatment of depressive disorders in the general
population and the workplace
In the past twenty years, research on effective treatments
for depression has been extensive [22-25]. Several meta-
analyses have shown that depressive disorders can be
treated effectively with pharmacotherapy, psychotherapy,
or a combination of pharmacotherapy and psychother-
apy [22-24]. More recently, the number of studies exam-
ining the effect of self-help treatment for mental
disorders has increased substantially, especially for stud-
ies examining the effect on depressive disorders [26-28].
In addition, self-help delivered via the Internet with
guidance of a professional counsellor has become avail-
able. Research has shown that the effect of this type of
treatment is promising [27,29,30].
Compared to treatments for depression in general
healthcare, the evidence for effective worker-directed
treatments of employees with depressive symptoms is
scarce [31]. Considering the importance of work-related
factors in the development and perpetuation of depres-
sion, it may be important to involve the employability,
disability in job performance and the work setting of the
patient in depression treatment [31]. Treatment of
employees with depressive symptoms can be either
carried out in the workplace or in general healthcare.
In the Netherlands, the standard care for sick-listed
employees with depressive symptoms in the workplace is
treatment by an occupational physician. An evidence-
based guideline for treatment of psychological problemsin general is available for occupational physicians. How-
ever, this guideline does not focus on depression specific-
ally [32]. In recent years, some research has been done on
effective treatment of sick-listed employees with mental
health problems; however, results are conflicting [33-36].
Yet, there is hardly any evidence on effective treatments of
depressive symptoms for employees who are not on sick
leave [37]. Recently, Lexis et al. [37] showed positive
results of a problem-solving treatment for employees with
a high risk for sick leave due to depressive symptoms.
However, in this study the severity of the depressive
symptoms was low and the number of treatment sessions
with a psychologist varied. Gärtner et al. [38] have started
a study on the effect of a Workers’ Health Surveillance
mental module for health service workers with mental
health complaints. The goal of the module is to improve
employees’ mental health and work functioning. Results of
the study are not published yet. To our knowledge, these
are the only studies in which the effect of a treatment for
employees with mental health complaints who are not on
sick leave is tested.
Study objective
Companies pay a substantial part of the costs for depres-
sive disorders due to work absenteeism and loss of work
productivity [11]. An indicated preventive strategy to re-
duce mild to moderate depressive symptoms in employees
who are not (yet) on sick leave could lower the costs for
companies by reducing work absenteeism and loss of work
productivity [16]. A guided self-help treatment might be a
valuable and cost efficient strategy to treat employees with
mild to moderate depressive symptoms. Therefore, we
developed a web-based guided self-help course for
employees with depressive symptoms who are not on sick
leave. The aim of this study is to examine the effectiveness
and cost-effectiveness of the self-help course called




This study is a randomized controlled trial. Subjects will
be randomized into two groups: an Internet guided self-
help course or care-as-usual. The study protocol, infor-
mation leaflet, and informed consent form were
approved by the Medical Ethics Committee of the VU
University Medical Center (registration number 2011/2).
We use the CONSORT- EHEALTH guideline for
reporting randomized controlled trials concerning
ehealth [39]. The study design is shown in Figure 1.
Inclusion and exclusion criteria
Employees with an increased level of depressive
symptoms from companies with white collar workers
Invitation with study information and informed consent to 
every employee who shows interest in the study (by 
emailing their name and private emailaddress)
Randomization
Return of informed consent
Subjects not returning 
informed consent
Baseline measurement (T0)




- Unstable use of medication
- Legal labor dispute
- Treatment from occupational care  







Self-help book of 
Happy@Work
Follow-up 6 months (T2)
Follow-up 12 months (T3)
Follow-up 6 months (T2)
Follow-up 12 months (T3)
Figure 1 Overview of study procedure.
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Netherlands who are willing to enroll in a web-based
guided self-help course are eligible for taking part in this
study. Inclusion criteria are: 18 years of age or older,
elevated depressive symptoms (scoring 16 or higher on
the Center for Epidemiologic Studies Depression – scale
[CES-D]), access to the Internet and an e-mail address.
Exclusion criteria are: partial or full work absenteeism, re-
ceiving treatment from the company’s occupational healthcare at study entrance, unstable (<1 month) medication
use for depressive symptoms, and having a legal labor dis-
pute with the employer.
Recruitment
Subjects will be recruited via different methods such as
banners on the company’s intranet, pamphlets and
posters. Subjects who are interested in taking part in the
study can ask for more information about the study via
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researchers will send an information leaflet and an
informed consent form via email. The informed consent
form can be returned via post or e-mail. Additionally,
subjects will receive an e-mail with a link to an online
screening questionnaire. Subjects who are eligible to take
part will be included.
Randomization
Randomization will take place at an individual level after
completion of the baseline measurement (questionnaire
and clinical interview). We will use stratification at two
levels: 1. use of antidepressants and 2. receiving treatment
from a psychologist or psychiatrist at study entrance. Block
randomization will be used with random blocks containing
4, 6 or 8 allocations. An independent researcher will make
the allocation schedule with a computerized random num-
ber generator and the investigators will be unknown to the
schedule. Subjects will be randomized into two groups: the
intervention group or the care-as-usual group. Subjects will
be informed about the randomization outcome via e-mail.
Subjects in the intervention group will usually start with
the intervention on the first Monday after randomization.
Intervention
Intervention group
The intervention Happy@Work is a brief web-based inter-
vention with guidance. It is based on Problem Solving
Treatment (PST) [40], Cognitive Therapy (CT) [41] and a
guideline to help employees with stress symptoms [42,43].
We adapted the content of an evidence based web-based
PST intervention called “Allesondercontrole” (i.e. “Every-
thing Under Control”) [29] and added exercises and
examples. Furthermore, we included information and
exercises about automatic thoughts and a mood diary
(CT). In PST, it is assumed that depressive symptoms can
be caused by practical problems that people face in their
daily lives. It is believed that, when people can resolve
their problems, their symptoms of depression will de-
crease [29]. The PST will help them solve their problems.
Sometimes, however, problem solving can be disrupted by
automatic thoughts such as ‘’I am too weak to solve this
problem” or “I will fail solving this problem”. PST may not
be sufficient to change these automatic thoughts that
disrupt problem solving. Therefore, we incorporated CT
information and exercises to change these automatic
thoughts in the course [41]. Some of the problems that
people face are likely to be work-related. These problems
are sometimes more difficult for people to comprehend
[42,43]. Therefore, one lesson is focused on work-related
problems specifically. All examples in the intervention
apply to white collar workers.
Participants will receive a username and password at
the beginning of the course for secured and personalaccess to the website. Participants follow one lesson per
week. Each lesson has a different theme, but always
follows the same structure: information about the theme,
examples, and assignments. When participants have
finished the assignments, they will submit them via the
website. A new lesson can be started after receiving the
feedback from the coach (i.e. tunnelled intervention).
A coach will provide written weekly support via the
website after a lesson has been completed. The support
will be delivered by occupational social workers from
the company or by Master level students in clinical
psychology when occupational social workers are not
available. The support includes feedback on the
assignments, what went well and what can be improved.
Additionally, we will also use motivational and empathic
strategies to keep participants engaged in the course.
Development of a patient-therapist alliance, as in trad-
itional psychotherapy, is not an aim of the support.
The support will be placed on the website by the coach
within three working days after the lesson was completed
by the participant. All support will be reviewed by a super-
vising psychologist (usually the first author of this paper)
to ensure the quality of the support. An automatic email
will be send to participants once the support is placed on
the website by the coach. The e-mail informs participants
that support is provided, describes the theme of the next
lesson, and contains the deadline for the next assignment.
Email reminders will be sent to the participant when
deadlines are not met.
The coaches will receive a six hour training consisting
of education about problem solving therapy, explanation
of the treatment manual which is used throughout the
course, and practice with case material. The training will
be provided by a supervising psychologist (usually the
first author of this paper).
Care-as-usual group
Subjects in the care-as-usual (CAU) group will not re-
ceive treatment or support from the researchers. How-
ever, they are free to seek any help they want. In an
email containing the randomization outcome they will
be advised to consult their (occupational) physician or a
psychologist if they want treatment for their depressive
symptoms. Subjects who are interested in receiving
the self-help book version of the intervention will re-
ceive a copy after they have completed the post-
treatment assessment.
Assessments
There will be a total of four assessments. The first as-
sessment (baseline, T0) will be before the start of the
intervention. Other assessments will be taken at 8 weeks
(T1), 6 months (T2), and 12 months (T3) after baseline.
At T0 and T2 a clinical interview, for diagnostic
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Depressive symptoms Symptoms of depression will be
measured with the Center for Epidemiological Studies
Depression – scale (CES-D) [44]. This questionnaire is
widely used for identifying people with depressive
symptoms. Its validity has been tested in different
populations [44-47]. The CES-D consists of 20 items
and the total score varies between 0 and 60. A score of
16 or higher represents a clinically significant level of
depressive symptoms [44]. The cut-off score of 16 will
be used in this study as an inclusion criterion.
Secondary outcomes
Work absenteeism
Work absence will be measured via self-report with the
TiC-P (see Costs: health care utilization and production
loss). Additionally, sick leave data from the companies
will be used when available and can be merged into fre-
quency and duration of sick leave during the time of the
inclusion period of the study (12 months).
Work performance
We will use the general work performance scale of the
WHO Health and Work Performance Questionnaire
(HPQ) [48] which contains four items. Subjects will
score the general work performance of other colleagues,
their own usual work performance during the last two
years, their overall work performance during the past
four weeks, and their overall work performance during
the past four weeks when compared to their colleagues.
Every item will be scored from 0 to 10, with higher
scores indicating better work performance [49].
Burnout symptoms
Burnout symptoms will be measured with the Dutch
version of the Maslach Burnout Inventory-General Scale
(MBI) [50], called the UBOS [51]. This self-report ques-
tionnaire contains 15 items and three dimensions: Ex-
haustion (5 items); Cynicism (4 items); Reduced
professional efficacy (6 items). For every dimension a
total score will be calculated. Participants with a high
score on Exhaustion and a high score on Cynicism or a
low score on Reduced professional efficacy will be
considered as “burnout” [51].
Anxiety symptoms
The anxiety subscale of the Hospital Anxiety and De-
pression Scale (HADS) will be used to measure anxietysymptoms [52]. The anxiety subscale of the HADS
consists of 7 items. Scores range from 0 to 21 with
higher scores indicating more anxiety. The HADS has
shown good homogeneity and reliability in different nor-
mal and clinical Dutch samples [53].
Quality of life
Quality of life will be assessed with the EQ-5D (EuroQol)
[54]. The EQ-5D is a well validated instrument for meas-
uring general health-related quality of life. It consists of 5
dimensions (mobility, self-care, usual activities, pain/dis-
comfort, and anxiety/depression) which are rated as
causing ‘no problems’, ‘some problems’ or ‘extreme
problems’. The EQ-5D distinguishes 245 unique health
states. Each unique health state can be assigned with a
utility score which ranges from 0 (poor health) to 1 (per-
fect health). We will use such single EQ-5D summary
index scores obtained in the Dutch population to calculate
quality-adjusted life-years (QALYs) [55]. The EQ-5D also
contains a Visual Analogue Scale (VAS) on which subjects
rate their own health between 0 (worst imaginable health
state) and 100 (best imaginable health state).
Costs: health care utilization and production loss
A revised version of the Trimbos and iMTA Question-
naire on Costs Associated with Psychiatric Illness (TiC-P)
[56] will be used to collect data on direct and indirect
costs from the subjects. The TiC-P is a self-report ques-
tionnaire and consists of two different parts that can be
administrated separately. Part I consists of 12 items and is
concerned with measuring healthcare utilization by
subjects. Questions on the frequency of utilization of
health care services of the company such as occupational
physician and social work were added to this part of the
TiC-P.
Part II (Short Form Health and Labor Questionnaire
[SF-HLQ]) is meant to determine lost productivity costs
resulting from absenteeism (being absent from work be-
cause of illness) and presenteeism (being present at work
while ill which may lead to reduced efficiency) and
consists of 11 items.
The TIC-P can be assessed with different recall periods
[56,57]. At all assessments we will use the time period
between the current assessment and the previous assess-
ment. For the baseline assessment a recall period of
three months will be used.
Clinical interview
The World Health Organization Composite Inter-
national Diagnostic Interview (CIDI, version 2.1) [58] is
a structured interview to assess psychiatric diagnosis
defined in the Diagnostic and Statistical Manual of the
American Psychiatric Association, 4th edition (DSM-IV)
[59]. For this study, two sections of the CIDI will be
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order section, and the “other” anxiety disorders (social
phobia, panic disorder, agoraphobia and generalized anx-
iety disorder) section. The assessment typically lasts 20–
45 minutes, depending on the mental state of the sub-
ject. The CIDI will be conducted by trained interviewers
via telephone at baseline (T0) and after 6 months (T2).
Other outcomes
We will use mastery and social support in explorative
analyses as possible mediators or moderators.
We expect that the effectiveness of the intervention
Happy@Work will be depended on mastery. A previous
study by Warmerdam et al. [60] on the effectiveness of
“Allesondercontrole” has shown a mediating effect of mas-
tery. Happy@Work is based on this intervention
“Allesondercontrole.” We will also investigate the possible
mediating or moderating effect of social support because
increasing the social support is an important theme in
Happy@Work. Furthermore, social support has been
proven to be an important predictor of depression [61-63].
Furthermore, we will use a course evaluation question-
naire and a non-response questionnaire to gain insight
in the use of the intervention.
Mastery
The Pearlin Mastery Scale [64] contains 7 items and
measures how much an individual perceives having con-
trol over things in his or her life. The total score ranges
from 7 to 35. A high score (internal mastery) indicates
that the subject generally feels in control of situations. A
low score (external mastery) indicates that the subject
generally has the feeling of being that things are out of
his own control. This questionnaire has good psycho-
metric properties [64].
Social support and conflicts
Eight items concerning social support from coworkers
and supervisors and one item concerning conflicts with
the supervisor will be used. These items are from the
Netherlands Working Conditions Survey [65]. The items
are based on Karasek’s concepts of “Supervisory support”
and “Co-worker support” from the Job Content Ques-
tionnaire (JCQ) [66], and were translated into Dutch by
Houtman et al. [67].
Course evaluation
We will use an Internet Intervention Evaluation Question-
naire [van Straten, unpublished data] to gain information
from the intervention group about their experiences with
the intervention. This questionnaire contains both quanti-
tative (e.g. grades for website, feedback etc.) and qualita-
tive (e.g. suggestions for improvement of the website,
perceived effectiveness of the course etc.) questions.Non response
An adapted version of the Internet Intervention Adherence
Measure [68] will be used to identify obstacles that inter-
fere with the participant completing the Internet course.
Obstacles are categorized as Internet/computer/technical
issues, Personal/family issues, Intervention-general issues,
and Intervention-specific issues. Participants will respond
to the 29 items on a 3-point scale from 1 to 3, indicating
whether that obstacle has had ‘no part’ , ‘a small part’, or ‘a
major part’ in why they stopped using the Internet course.
This questionnaire will be send to the participant when he
reports to stop with the Internet course or when the par-
ticipant will not show any activity on the website during a
continuous period of three weeks.
Other questions
We will add demographic variables, medication use for
psychological problems and treatment by a mental health
specialist to the questionnaire at baseline assessment.
For an overview of the outcome measurements see Table 1.
Process evaluation
The process evaluation will be conducted alongside the
study with use of the guideline of Steckler and Linnan [69].
In a process evaluation, Steckler and Linnan [69] advise to
include several key process evaluation components. These
components are: context, reach, dose delivered, dose
received, fidelity, implementation, and recruitment. We
will add perceived effectiveness as another key component.
Data for the process evaluation will be obtained via the
course evaluation questionnaire at T1. Data from the non-
response questionnaire will be used to assess reasons for
not completing the Internet course. Furthermore, we will
use information from the website to determine compli-
ance, percentage of participants completing the course,
and to gain information on the number of lessons
participants have completed. If possible we will evaluate
the coaches’ experiences with the website, giving feedback,
and preferences for use of the website in the future.
Sample size
The sample size of this study is based on the expected
difference on the primary outcome variable (i.e. depres-
sive symptoms) between the intervention group and the
CAU group. Based on a power of 0.80, an alpha of 0.05,
and an expected drop-out percentage of 30%, we will
need 100 subjects in each condition to show an effect-
size of 0.50 (based on previous research [29,30]). There-
fore, the total sample size is determined at 200.
Statistical analysis
Analyses will be conducted according to the intention-to-treat
principle (ITT). Handling of missing data will be
determined after the inclusion period of the study.
Table 1 Overview of outcome measurements
Time of measurement








CES-D Symptoms of depression X X X X
Work absenteeism Self-report of absence from work and objective
sick leave data
X X X X
Work performance General work performance in different time
periods
X X X X
MBI/UBOS Burnout symptoms X X X X
HADS Anxiety symptoms X X X X
EQ5D Quality of life X X X X
TiC-P Health care utilization and production losses X X X X
CIDI Diagnostic interview X X
Mastery Perceived control X X X X
Social support and
conflicts
Social support from coworkers and supervisor and
conflicts with supervisor
X X X X
Course evaluation Satisfaction with Happy@Work (only intervention
group)
X
Other questions Characteristics X
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group and the CAU group we will use regression ana-
lyses. A multilevel analytic approach will be used if non-
independence of observations is an issue in the data and
will be determined by calculating the Intra Class
Correlations (ICC). We will also use Cohens’ d to meas-
ure the size of the effect. Effect sizes of 0.8 are assumed
to be large; effect sizes of 0.5 are moderate; and effect
sizes of 0.2 are assumed to be small [70].
Clinical significant change will be determined with
norms for the primary outcome measure and with the Re-
liable Change Index [44,71]. We will use the cut-off score
of 16 on the CES-D as an indication of recovery. Reliable
Change will be used as an index for improvement.
The explorative analyses of the possible mediating and
moderating effects of mastery and social support will be
tested as suggested by MacKinnon [72].
Economic analyses
The economic evaluation will be performed from both
the societal and company’s perspective.
Costs typically have a highly skewed distribution. Pol-
icy makers need information on the difference in mean
total costs between the intervention group and the CAU
group to be able to estimate the total health care budget
needed for a specific condition [73]. Therefore, bias-
corrected and accelerated bootstrapping with 5000
replications will be used to estimate 95% confidence
intervals around the mean difference in total costs be-
tween the treatment groups.
Incremental cost-effectiveness ratios (ICERs) will be
calculated by dividing the difference in mean total costsbetween the intervention group and the CAU group by
the difference in mean effects between the groups. The
ICER is expressed in terms of additional costs per clinic-
ally significant change in depressive symptoms severity
(cost-effectiveness analysis) and in terms of Quality
Adjusted Life Years (QALY) (cost-utility analysis). Boot-
strapping will be used to estimate the uncertainty
surrounding the ICERs which will be graphically presented
on cost-effectiveness planes. Cost-effectiveness acceptabil-
ity curves and net monetary benefits will also be
calculated. Cost-effectiveness acceptability curves show
the probability that the intervention is cost-effective in
comparison with usual care for a range of different ceiling
ratios thereby showing decision uncertainty [74]. We will
also perform a cost-benefit analysis from the company’s
perspective in which the costs of the intervention will be
compared to benefits in absenteeism, depression and work
performance.
Discussion
In this randomized controlled trial we will compare a
group which will follow an indicated preventive web-
based guided self-help course for non-sick-listed
employees with depressive symptoms with a care-as
-usual control group. To our knowledge, this is the first
study in the field of depression treatment for employees
which has an e-mental health approach that is aimed at
reducing depressive symptoms and preventing sick leave.
If proven effective, the results of this study could stimu-
late the use of web-based interventions in the worksite
setting. In this study the effectiveness of the web-based
guided self-help course will be studied in the workplace,
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healthcare.
The described study design has several limitations.
First, the study population will consist of white collar
workers; therefore, our results have limited external val-
idity. However, it is difficult to develop an intervention
which is applicable to all occupational groups because of
variations in occupations and specific job demands. In
this study we have chosen to focus on white collar
workers and we expect to adjust the intervention for
other occupational groups, such as nursing staff, if this
current study population yields positive results.
Second, we will try to recruit subjects via different re-
cruitment methods and companies but it is probable that
we do not reach all employees with depressive symptoms.
In addition, some employees with depressive symptoms
may hesitate to participate in this study because of doubts
about confidentiality and anonymous participation re-
garding their manager or employer. Due to an economic
recession during the inclusion period of this study (2011–
2012) job security is low. Hence, employees may be more
anxious about losing their job in case their manager or
employer will find out about their depressive symptoms
and participation in this study. We will try to minimize
this potential selection-bias by placing a clear explanation
about the privacy and confidentiality of the employee in
the information leaflet.
Despite these limitations, this study also has several
strengths. One of these strengths concerns the economic
evaluation which will be performed both from a societal
and a company’s perspective. The main advantage of the
societal perspective is that all costs and consequences
(regardless of who pays or receives) will be taken into
consideration. However, the results of the economic
evaluation from the societal perspective are not directly
interpretable for company decisions because they may
include certain costs and consequences that are not rele-
vant from the company’s point of view [75]. For ex-
ample, resource use and costs of alternative health care
is relevant from a societal perspective, but not from a
company’s perspective. Therefore, it is also important to
perform an economic evaluation from the company’s
perspective. Furthermore, in the economic evaluation
from the company’s perspective we can calculate the
cost-benefits in use of the health care services from the
company.
Another important strength of this study concerns the
methodology. We will use a diagnostic interview at base-
line and follow-up assessment. Using a diagnostic inter-
view gives us the opportunity to describe percentages of
participants meeting the criteria of a depressive disorder.
It will also make our study comparable with other stud-
ies. Another methodological strength concerns the dif-
ferent options of methods that we will have to measurework absenteeism. Since a golden standard for collecting
sick leave data does not exist, using both self-report and
objective sick leave data from a database gives us the op-
portunity to use the advantages of both methods [75]
which may lead to more accurate sick leave data. How-
ever, it may be difficult to compare the sick leave
databases of the companies due to use of different
methods and the accuracy of registration. At this mo-
ment, we do not know whether it is possible to use ob-
jective sick leave data as well. The final strength of this
study is the process evaluation. It will give us insight in
the implementation, effectiveness, and execution of the
intervention.
This study will be performed in the period from 2011
until 2013 and recruitment has started in September
2011. This will be the first study in the worksite setting
that will focus especially on a web-based treatment for
employees with depressive symptoms.
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